Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders. AJPS. 2026;25(5):917-930. doi:10.32947/ajps.v25i5.1307